JMJorge Andrés Urquijo Méndez

Jorge Andrés Urquijo Méndez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jorge Andrés Urquijo Méndez has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cost-utility analysis of CAR-T therapy compared to standard of care in patients with relapsed/refractory diffuse large B-cell lymphoma in Colombia, 2025

    by Alexandra Porras Ramírez, Alejandro Rico Mendoza, Liliana Encinales, Oscar Madiedo, María Fernanda Campos Maya, Juan Fernando Ramón Cuellar, Jorge Andres Urquijo Méndez

  • Open Access

    Clinical and Economic Trade-Offs in Antifungal Therapy for Invasive Aspergillosis and Mucormycosis: A Markov Model–Based Analysis

    by Alejandro Rico Mendoza, Alexandra Porras Ramirez, Liliana Encinales, Oscar Madiedo, Marianna Carrillo Encinales, Juan Pablo Duque Bolivar, Juan Fernando Ramon Cuellar, Jorge Andrés Urquijo Mendez, Zuly Moreno Perilla, Roberto Jurado Zambrano

    Invasive aspergillosis and mucormycosis are life-threatening fungal infections characterized by high early mortality, substantial toxicity, and intensive healthcare resource utilization. While multiple antifungal therapies are recommended in international guidelines, their comparative clinical and economic value remains uncertain, particularly in resource-limited settings. We developed a hybrid decision tree and Markov model to evaluate antifungal strategies, including liposomal amphotericin B, isavuconazole, voriconazole, posaconazole, and caspofungin, from the perspective of the Colombian healthcare system over a 6-month horizon. Health states included clinical response, treatment failure, toxicity, and death. Outcomes included quality-adjusted life-years (QALYs), costs, incremental cost-effectiveness ratios (ICERs), and net monetary benefit (NMB). Deterministic and probabilistic sensitivity analyses were performed. In invasive aspergillosis, isavuconazole provided a modest incremental benefit over voriconazole (+0.022 QALYs), driven primarily by improved tolerability, at an incremental cost of COP 3.4 million, yielding an ICER of COP 154.5 million/QALY. In mucormycosis, liposomal amphotericin B yielded greater survival benefits (+0.035 QALYs) but at substantially higher costs (ICER: COP 494.3 million/QALY). Across willingness-to-pay thresholds, isavuconazole and voriconazole demonstrated more favorable economic profiles, owing to lower toxicity and reduced hospitalizations. These findings highlight that the clinical–economic value of antifungal therapy is primarily determined by early survival gains, toxicity burden, and front-loaded costs. Strategies minimizing toxicity and hospitalization appear more efficient in constrained health systems, whereas survival-maximizing approaches may be justified in severe disease. This integrated analysis supports context-specific antifungal decision-making in the management of invasive fungal infections.

  • Open Access

    Clinical and donor-site outcomes of DIEP versus TRAM flaps in post-mastectomy breast reconstruction: a systematic review and meta-analysis

    by Jorge Andrés Urquijo Méndez, Alejandro Rico-Mendoza, Alexandra Porras-Ramírez

    Background: Autologous breast reconstruction continues to be a cornerstone of post-mastectomy reconstruction, with abdominally based flaps providing reliable aesthetic and functional outcomes. Of these approaches, the deep inferior epigastric perforator (DIEP) flap and the transverse rectus abdominis myocutaneous (TRAM) flap are the most commonly used. However, controversy exists surrounding their relative effectiveness, complication profile, donor-site morbidity, and reported outcomes. Methods: A systematic review and meta-analysis were undertaken according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. A search was conducted across PubMed, Scopus, Embase, and Web of Science for comparative studies published between January 2000 and December 2025 that assessed DIEP and TRAM flap breast reconstruction. Outcomes included total flap loss, fat necrosis, donor-site morbidity, abdominal wall complications, and patient-reported outcomes. Random-effects meta-analyses were performed employing pooled odds ratios (ORs) and 95% confidence intervals (CIs). Heterogeneity was evaluated by Cochran’s Q and Higgins’ I² statistics. An exploratory network meta-analysis was also performed to compare DIEP with other autologous reconstructive techniques, such as transverse upper gracilis (TUG), transverse myocutaneous gracilis (TMG), profunda artery perforator (PAP), and inferior gluteal artery perforator (IGAP) flaps. Results: Ten studies met the inclusion criteria for the qualitative synthesis, yet five also provided quantitative data that were included in the meta-analysis. Pooled analysis showed no significant difference in fat necrosis between reconstructive techniques (OR: 0.86; 95% CI: 0.54–1.36; I² = 34.6%). Likewise, the total flap loss rates were similar between DIEP and TRAM flaps (OR: 0.79; 95% CI: 0.39–1.61; I² = 7.2%). DIEP reconstruction was consistently associated with fewer donor-site morbidities and significantly better maintenance of abdominal wall health than the TRAM flap. Among exploratory network meta-analysis studies, the TUG flap showed clear superiority in reduced total flap loss, while DIEP flaps ranked favorably in donor-site outcomes and patient satisfaction. Conclusions: DIEP and TRAM flaps have comparable flap survival and overall reconstructive efficacy in post-mastectomy breast reconstruction. DIEP reconstruction appears to offer the best performance in reducing donor-site morbidity while preserving abdominal wall integrity. There was no single reconstruction technique that consistently outperformed all other reconstructive approaches across all outcomes, reinforcing an individualized surgical approach based on patient anatomy, comorbidities, reconstruction goals, and surgeon expertise.

  • Open Access

    Toxicities associated with CAR-T therapy compared with standard treatments in hematologic malignancies: a systematic review and meta-analysis

    by Alexandra Porras Ramírez, Alejandro Rico Mendoza, Liliana Encinales, Oscar Madiedo, Marianna Carrillo Encinales, Juan Pablo Duque Bolívar, Juan Fernando Ramón Cuellar, Jorge Andrés Urquijo Méndez, Alexandra Marín Morales, Zuly Moreno Perilla, et al.

    Chimeric antigen receptor T-cell (CAR-T) treatment has revolutionized the therapeutic approach for relapsed or refractory hematologic malignancies. But its


  • Open Access

    Identificación de riesgos biomecánicos y trastornos musculoesqueléticos en docentes de una Facultad de Medicina en Bogotá, 2024

    by Jorge Andres Urquijo Mendez, María Camila Robayo Barrera, Gabriela Sarmiento González, Isabella Sarmiento Mejía, Juan Jose Villarreal Torres, Martha Inés López Trujillo, Aldo Piñeda Geraldo

    Introducción. La docencia implica diversos riesgos biomecánicos debido a posturas prolongadas y movimientos repetitivos, lo que convierte a los profesores en una población propensa a desarrollar trastornos musculoesqueléticos (TME). Este estudio se centró en identificar los principales riesgos en docentes de la Facultad de Medicina de la Universidad El Bosque en el periodo 2024-1; se consideraron variables sociodemográficas y ocupacionales y se indagó sobre la percepción de síntomas musculoesqueléticos. Objetivo. Identificar los principales riesgos biomecánicos y osteomusculares en docentes de la Facultad de Medicina de la Universidad El Bosque. Métodos. Estudio de corte transversal cuantitativo, aplicado a 52 docentes del área Bioclínica de la Facultad de Medicina, mediante la aplicación de una encuesta que incluyó un cuestionario estructurado junto con el Cuestionario Nórdico Estandarizado Kuorinka de 1987. El análisis descriptivo se llevó a cabo con las frecuencias, medidas de tendencia central y dispersión. El análisis comparativo se realizó mediante pruebas estadísticas para variables cuantitativas y cualitativas con el software SPSS y Jamovi. Resultados. Se identificó la prevalencia de síntomas musculoesqueléticos, especialmente en cuello y columna lumbar. Estas molestias se relacionan con las posturas prolongadas sedentes o en bipedestación, así como con cargas horarias elevadas. Se observaron diferencias significativas según el sexo, el índice de masa corporal y el tiempo semanal laborado. Conclusiones. Los principales riesgos biomecánicos y osteomusculares se asociaron con horarios extensos, sedentarismo y posturas sedentes o bípedas mantenidas. La sintomatología musculoesquelética fue más prevalente en mujeres. La actividad física se identificó como un factor protector. Hubo significancia estadística (p = 0,007) entre la postura laboral y la presencia de dolor lumbar. El estudio resalta la necesidad de estrategias ergonómicas y preventivas para reducir la incidencia de TME y mejorar la calidad de vida y el desempeño laboral docente.